Sidley Austin has advised Werewolf Therapeutics. Cooley has advised Ambros Therapeutics. Latham & Watkins has advised the placement agents. Werewolf Therapeutics, Inc. (NASDAQ: HOWL) and Ambros...
Werewolf and Ambros Therapeutics Announce All-Stock Merger and $150 Million Private Placement
Crossbow Therapeutics Secures US$77 Million Series B Funding to Advance Cancer Immunotherapy Program
Sidley has advised Crossbow Therapeutics on the deal. Crossbow Therapeutics, a biotechnology company specializing in the development of next-generation antibody therapies targeting a wide range of...
BioCryst Pharmaceuticals to Acquire Astria Therapeutics for $920 Million
Covington & Burling LLP has advised BioCryst Pharmaceuticals, Inc., and Sidley Austin LLP has advised Astria Therapeutics, Inc. BioCryst Pharmaceuticals, Inc. has entered into a definitive...
Fortra’s Acquisition of Lookout’s Cloud Security Business
Wilmer Cutler Pickering Hale and Dorr represented Lookout in the transaction. Fortra, LLC, a company dedicated to breaking the cyber attack chain with advanced offensive and...
Beam Therapeutics’ $500 Million Common Stock Offering
Wilmer Cutler Pickering Hale and Dorr represented Beam Therapeutics Inc., and Davis Polk & Wardwell advised the underwriters in the offering. Beam Therapeutics Inc. (Nasdaq: BEAM)...
Medtronic’s €3.0 Billion Senior Notes Offering
Wilmer Cutler Pickering Hale and Dorr represented Medtronic, Inc. in the offering. Medtronic plc (NYSE: MDT) announced it closed its €3 billion public offering, consisting of...